Amundi Asset Management US’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Amundi Asset Management US's DGX Position: Q1 2021 in Review
Amundi Asset Management US increased its Quest Diagnostics (DGX) stake by 7.9% in Q1 2021, buying an estimated $14.9M and bringing the position to 1,644,311 shares worth $211M. The position accounts for 0.16% of the portfolio, ranked #144.
Amundi Asset Management US first reported a position in DGX in Q1 2015 and has held it in 20 quarters since. The position peaked at $950M in Q2 2019. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.
- Amundi Asset Management US held 1,644,311 shares of Quest Diagnostics worth $211M as of Q1 2021.
- Amundi Asset Management US bought 120,831 Quest Diagnostics shares in Q1 2021, an estimated $14.9M.
- Quest Diagnostics made up 0.16% of Amundi Asset Management US's portfolio in Q1 2021, its #144 holding.
- Amundi Asset Management US first reported a position in Quest Diagnostics in Q1 2015 and has held it in 20 quarters since.
- Amundi Asset Management US's Quest Diagnostics position peaked at $950M in Q2 2019.
- 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.